Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025
- QYR2792307
- 116 Pages
- October 2018
- Pharmaceuticals
Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.
Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The factors driving this market include increasing hospitalization rate and rise in demand for faster, safer and effective administration of drugs. The introduction of single dosage nervous system disorders, oncology and diabetes would provide opportunities for growth of this market.
In 2017, the global Large Volume Parenteral (LVP) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Large Volume Parenteral (LVP) market based on company, product type, application and key regions.
This report studies the global market size of Large Volume Parenteral (LVP) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Large Volume Parenteral (LVP) in these regions.
This research report categorizes the global Large Volume Parenteral (LVP) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Large Volume Parenteral (LVP) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Large Volume Parenteral (LVP) include
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Southwest Pharmaceutical
Cook Pharmica
Beximco Pharma
Baxter Healthcare Corporation
Market Size Split by Type
Fluid Balance Injections
Therapeutic Injections
Nutritious Injections
Market Size Split by Application
Hospitals
Medical Centers
Others
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Large Volume Parenteral (LVP) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Large Volume Parenteral (LVP) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Large Volume Parenteral (LVP) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Large Volume Parenteral (LVP) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Large Volume Parenteral (LVP) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Large Volume Parenteral (LVP) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Large Volume Parenteral (LVP) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Large Volume Parenteral (LVP) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type
1.4.2 Fluid Balance Injections
1.4.3 Therapeutic Injections
1.4.4 Nutritious Injections
1.5 Market by Application
1.5.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Medical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Large Volume Parenteral (LVP) Market Size
2.1.1 Global Large Volume Parenteral (LVP) Revenue 2016-2025
2.1.2 Global Large Volume Parenteral (LVP) Sales 2016-2025
2.2 Large Volume Parenteral (LVP) Growth Rate by Regions
2.2.1 Global Large Volume Parenteral (LVP) Sales by Regions
2.2.2 Global Large Volume Parenteral (LVP) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Large Volume Parenteral (LVP) Sales by Manufacturers
3.1.1 Large Volume Parenteral (LVP) Sales by Manufacturers
3.1.2 Large Volume Parenteral (LVP) Sales Market Share by Manufacturers
3.1.3 Global Large Volume Parenteral (LVP) Market Concentration Ratio (CR5 and HHI)
3.2 Large Volume Parenteral (LVP) Revenue by Manufacturers
3.2.1 Large Volume Parenteral (LVP) Revenue by Manufacturers (2016-2018)
3.2.2 Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2016-2018)
3.3 Large Volume Parenteral (LVP) Price by Manufacturers
3.4 Large Volume Parenteral (LVP) Manufacturing Base Distribution, Product Types
3.4.1 Large Volume Parenteral (LVP) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Large Volume Parenteral (LVP) Product Category
3.4.3 Date of International Manufacturers Enter into Large Volume Parenteral (LVP) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Large Volume Parenteral (LVP) Sales by Type
4.2 Global Large Volume Parenteral (LVP) Revenue by Type
4.3 Large Volume Parenteral (LVP) Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Large Volume Parenteral (LVP) Breakdown Data by Application
6 North America
6.1 North America Large Volume Parenteral (LVP) by Countries
6.1.1 North America Large Volume Parenteral (LVP) Sales by Countries
6.1.2 North America Large Volume Parenteral (LVP) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Large Volume Parenteral (LVP) by Type
6.3 North America Large Volume Parenteral (LVP) by Application
6.4 North America Large Volume Parenteral (LVP) by Company
7 Europe
7.1 Europe Large Volume Parenteral (LVP) by Countries
7.1.1 Europe Large Volume Parenteral (LVP) Sales by Countries
7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Large Volume Parenteral (LVP) by Type
7.3 Europe Large Volume Parenteral (LVP) by Application
7.4 Europe Large Volume Parenteral (LVP) by Company
8 Asia Pacific
8.1 Asia Pacific Large Volume Parenteral (LVP) by Countries
8.1.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Countries
8.1.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Large Volume Parenteral (LVP) by Type
8.3 Asia Pacific Large Volume Parenteral (LVP) by Application
8.4 Asia Pacific Large Volume Parenteral (LVP) by Company
9 Central & South America
9.1 Central & South America Large Volume Parenteral (LVP) by Countries
9.1.1 Central & South America Large Volume Parenteral (LVP) Sales by Countries
9.1.2 Central & South America Large Volume Parenteral (LVP) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Large Volume Parenteral (LVP) by Type
9.3 Central & South America Large Volume Parenteral (LVP) by Application
9.4 Central & South America Large Volume Parenteral (LVP) by Company
10 Middle East and Africa
10.1 Middle East and Africa Large Volume Parenteral (LVP) by Countries
10.1.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Countries
10.1.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Large Volume Parenteral (LVP) by Type
10.3 Middle East and Africa Large Volume Parenteral (LVP) by Application
10.4 Middle East and Africa Large Volume Parenteral (LVP) by Company
11 Company Profiles
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.1.4 Large Volume Parenteral (LVP) Product Description
11.1.5 Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.2.4 Large Volume Parenteral (LVP) Product Description
11.2.5 Recent Development
11.3 Kelun Pharma
11.3.1 Kelun Pharma Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.3.4 Large Volume Parenteral (LVP) Product Description
11.3.5 Recent Development
11.4 Cook Pharmica
11.4.1 Cook Pharmica Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.4.4 Large Volume Parenteral (LVP) Product Description
11.4.5 Recent Development
11.5 Patheon
11.5.1 Patheon Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.5.4 Large Volume Parenteral (LVP) Product Description
11.5.5 Recent Development
11.6 BAG Healthcare
11.6.1 BAG Healthcare Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.6.4 Large Volume Parenteral (LVP) Product Description
11.6.5 Recent Development
11.7 Southwest Pharmaceutical
11.7.1 Southwest Pharmaceutical Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.7.4 Large Volume Parenteral (LVP) Product Description
11.7.5 Recent Development
11.8 Cook Pharmica
11.8.1 Cook Pharmica Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.8.4 Large Volume Parenteral (LVP) Product Description
11.8.5 Recent Development
11.9 Beximco Pharma
11.9.1 Beximco Pharma Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.9.4 Large Volume Parenteral (LVP) Product Description
11.9.5 Recent Development
11.10 Baxter Healthcare Corporation
11.10.1 Baxter Healthcare Corporation Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Large Volume Parenteral (LVP)
11.10.4 Large Volume Parenteral (LVP) Product Description
11.10.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Large Volume Parenteral (LVP) Raw Material
13.1.2 Large Volume Parenteral (LVP) Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of Large Volume Parenteral (LVP)
Figure Global Large Volume Parenteral (LVP) Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Large Volume Parenteral (LVP) Production Market Share by Types (Product Category) in 2017
Figure Fluid Balance Injections Product Picture
Table Major Manufacturers of Fluid Balance Injections
Figure Therapeutic Injections Product Picture
Table Major Manufacturers of Therapeutic Injections
Figure Nutritious Injections Product Picture
Table Major Manufacturers of Nutritious Injections
Table Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals
Figure Medical Centers
Figure Others
Figure Large Volume Parenteral (LVP) Report Years Considered
Figure Global Large Volume Parenteral (LVP) Market Size 2016-2025 (Million US$)
Figure Global Large Volume Parenteral (LVP) Sales 2016-2025 (K Units)
Table Global Large Volume Parenteral (LVP) Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Large Volume Parenteral (LVP) Sales by Regions 2016-2025 (K Units)
Table Global Large Volume Parenteral (LVP) Sales Market Share by Regions 2016-2025
Figure Global Large Volume Parenteral (LVP) Sales Market Share by Regions 2016-2025
Figure 2017 Global Large Volume Parenteral (LVP) Sales Market Share by Regions
Table Global Large Volume Parenteral (LVP) Revenue by Regions 2016-2025 (Million US$)
Table Global Large Volume Parenteral (LVP) Revenue Market Share by Regions 2016-2025
Figure Global Large Volume Parenteral (LVP) Revenue Market Share by Regions 2016-2025
Figure 2017 Global Large Volume Parenteral (LVP) Revenue Market Share by Regions
Table Global Large Volume Parenteral (LVP) Sales by Manufacturers (2016-2018) (K Units)
Table Global Large Volume Parenteral (LVP) Sales Share by Manufacturers (2016-2018)
Figure Global Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2017
Table Large Volume Parenteral (LVP) Revenue by Manufacturers (2016-2018) (Million US$)
Table Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2016-2018)
Figure Large Volume Parenteral (LVP) Value Share by Manufacturers in 2017
Table Global Large Volume Parenteral (LVP) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Large Volume Parenteral (LVP) Price (2016-2018) (USD/Unit)
Table Large Volume Parenteral (LVP) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Large Volume Parenteral (LVP) Product Category
Table Date of International Manufacturers Enter into Large Volume Parenteral (LVP) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Large Volume Parenteral (LVP) Sales by Type (2016-2025) (K Units)
Table Global Large Volume Parenteral (LVP) Sales Share by Type (2016-2025)
Figure Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2025)
Figure Global Large Volume Parenteral (LVP) Sales Market Share by Type in 2017
Table Global Large Volume Parenteral (LVP) Revenue by Type (2016-2025) (Million US$)
Table Global Large Volume Parenteral (LVP) Revenue Share by Type (2016-2025)
Figure Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2025)
Figure Global Large Volume Parenteral (LVP) Revenue Market Share by Type in 2017
Table Large Volume Parenteral (LVP) Price by Type 2013-2018 (USD/Unit)
Table Global Large Volume Parenteral (LVP) Sales by Application (2016-2025) (K Units)
Table Global Large Volume Parenteral (LVP) Sales Share by Application (2016-2025)
Figure Global Sales Large Volume Parenteral (LVP) Market Share by Application (2016-2025)
Figure Global Sales Large Volume Parenteral (LVP) Market Share by Application (2016-2025)
Figure North America Large Volume Parenteral (LVP) Sales Growth Rate 2016-2025 (K Units)
Figure North America Large Volume Parenteral (LVP) Revenue Growth Rate 2016-2025 (Million US$)
Table North America Large Volume Parenteral (LVP) Sales by Countries (2016-2025) (K Units)
Table North America Large Volume Parenteral (LVP) Sales Market Share by Countries (2016-2025)
Figure 2017 North America Large Volume Parenteral (LVP) Sales Market Share by Countries
Table North America Large Volume Parenteral (LVP) Revenue by Countries (2016-2025) (Million US$)
Table North America Large Volume Parenteral (LVP) Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Large Volume Parenteral (LVP) Revenue Market Share by Countries
Figure United States Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure United States Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Table North America Large Volume Parenteral (LVP) Sales by Type (2016-2025) (K Units)
Table North America Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2025)
Figure 2017 North America Large Volume Parenteral (LVP) Market Share by Type
Table North America Large Volume Parenteral (LVP) Sales by Application (2016-2025) (K Units)
Table North America Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2025)
Figure 2017 North America Large Volume Parenteral (LVP) Market Share by Application
Table North America Large Volume Parenteral (LVP) Sales by Company (2016-2018) (K Units)
Table North America Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2018)
Figure North America Large Volume Parenteral (LVP) Sales Market Share by Company in 2017
Figure Europe Large Volume Parenteral (LVP) Sales Growth Rate 2016-2025 (K Units)
Figure Europe Large Volume Parenteral (LVP) Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Large Volume Parenteral (LVP) Sales by Countries (2016-2025) (K Units)
Table Europe Large Volume Parenteral (LVP) Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Large Volume Parenteral (LVP) Sales Market Share by Countries
Table Europe Large Volume Parenteral (LVP) Revenue by Countries (2016-2025) (Million US$)
Table Europe Large Volume Parenteral (LVP) Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Large Volume Parenteral (LVP) Revenue Market Share by Countries
Figure Germany Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (K Units)
Figure France Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure France Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (K Units)
Figure UK Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure UK Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Large Volume Parenteral (LVP) Sales by Type (2016-2025) (K Units)
Table Europe Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2025)
Figure 2017 Europe Large Volume Parenteral (LVP) Market Share by Type
Table Europe Large Volume Parenteral (LVP) Sales by Application (2016-2025) (K Units)
Table Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2025)
Figure 2017 Europe Large Volume Parenteral (LVP) Market Share by Application
Table Europe Large Volume Parenteral (LVP) Sales by Company (2016-2018) (K Units)
Table Europe Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2018)
Figure Europe Large Volume Parenteral (LVP) Sales Market Share by Company in 2017
Figure Asia Pacific Large Volume Parenteral (LVP) Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Large Volume Parenteral (LVP) Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Large Volume Parenteral (LVP) Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Countries
Table Asia Pacific Large Volume Parenteral (LVP) Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Countries
Figure China Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure China Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure India Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure India Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Large Volume Parenteral (LVP) Sales by Type (2016-2025) (K Units)
Table Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Large Volume Parenteral (LVP) Market Share by Type
Table Asia Pacific Large Volume Parenteral (LVP) Sales by Application (2016-2025) (K Units)
Table Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Large Volume Parenteral (LVP) Market Share by Application
Table Asia Pacific Large Volume Parenteral (LVP) Sales by Company (2016-2018) (K Units)
Table Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2018)
Figure Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Company in 2017
Figure Central & South America Large Volume Parenteral (LVP) Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Large Volume Parenteral (LVP) Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Large Volume Parenteral (LVP) Sales by Countries (2016-2025) (K Units)
Table Central & South America Large Volume Parenteral (LVP) Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Large Volume Parenteral (LVP) Sales Market Share by Countries
Table Central & South America Large Volume Parenteral (LVP) Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Large Volume Parenteral (LVP) Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Large Volume Parenteral (LVP) Revenue Market Share by Countries
Figure Brazil Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Large Volume Parenteral (LVP) Sales by Type (2016-2025) (K Units)
Table Central & South America Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Large Volume Parenteral (LVP) Market Share by Type
Table Central & South America Large Volume Parenteral (LVP) Sales by Application (2016-2025) (K Units)
Table Central & South America Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Large Volume Parenteral (LVP) Market Share by Application
Table Central & South America Large Volume Parenteral (LVP) Sales by Company (2016-2018) (K Units)
Table Central & South America Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2018)
Figure Central & South America Large Volume Parenteral (LVP) Sales Market Share by Company in 2017
Figure Middle East and Africa Large Volume Parenteral (LVP) Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Large Volume Parenteral (LVP) Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Large Volume Parenteral (LVP) Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Countries
Table Middle East and Africa Large Volume Parenteral (LVP) Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Countries
Figure GCC Countries Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Large Volume Parenteral (LVP) Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Large Volume Parenteral (LVP) Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Large Volume Parenteral (LVP) Market Share by Type
Table Middle East and Africa Large Volume Parenteral (LVP) Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Large Volume Parenteral (LVP) Market Share by Application
Table Middle East and Africa Large Volume Parenteral (LVP) Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Company in 2017
Table Ostuka Pharmaceutical Company Details
Table Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Ostuka Pharmaceutical Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Pharmaceutical Industries Recent Development
Table Kelun Pharma Company Details
Table Kelun Pharma Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Kelun Pharma Recent Development
Table Cook Pharmica Company Details
Table Cook Pharmica Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Cook Pharmica Recent Development
Table Patheon Company Details
Table Patheon Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Patheon Recent Development
Table BAG Healthcare Company Details
Table BAG Healthcare Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table BAG Healthcare Recent Development
Table Southwest Pharmaceutical Company Details
Table Southwest Pharmaceutical Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Southwest Pharmaceutical Recent Development
Table Cook Pharmica Company Details
Table Cook Pharmica Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Cook Pharmica Recent Development
Table Beximco Pharma Company Details
Table Beximco Pharma Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Beximco Pharma Recent Development
Table Baxter Healthcare Corporation Company Details
Table Baxter Healthcare Corporation Large Volume Parenteral (LVP) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Baxter Healthcare Corporation Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Large Volume Parenteral (LVP) Value Chain
Table Typical Suppliers of Key Large Volume Parenteral (LVP) Raw Material
Table Large Volume Parenteral (LVP) Customers List
Table Large Volume Parenteral (LVP) Sales Channels
Table Large Volume Parenteral (LVP) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
